Agnes Lehuen is director of the laboratory “Immunology of diabetes” at Cochin Institute and University Paris City, France. She is cofounder of the Laboratory of Excellence INFLAMEX.

Dr Lehuen research has been focused on autoimmunity and metabolic diseases. Her laboratory has highlighted the key role of innate immune cells in the initiation or the prevention of type 1 diabetes, with a particular interest on NKT and MAIT cells. She also reported MAIT cell alterations in type 1 and type 2 diabetes, obesity and liver diseases. Recently, her studies revealed that MAIT cell activation and cytotoxic function are associated with disease severity and mortality of COVID-19 patients.